![]() |
|||||||
| The Rare Diseases Clinical Research Network (RDCRN) aims to provide up-to-date information for patients and to assist in connecting patients with advocacy groups, expert doctors, and clinical research opportunities. | |||||||
|
|
||||||
The RDCRN is made up of 19 distinctive consortia that are working in concert to improve availability of rare disease information, treatment, clinical studies, and general awareness for both patients and the medical community. Click on the Consortium Name to view the diseases or disorders studied by each consortium. Clicking on a disease or disorder name will take you directly to a description of that disease or disorder. |
|||||||
[ go to web site ] |
[ study information coming soon!] |
||||||
|
[ study information coming soon!] |
[ study information coming soon!] |
||||||
|
[ study information coming soon!] |
[ study information coming soon!] |
||||||
[ go to web site ] |
[ study information coming soon!] |
||||||
|
[ study information coming soon!] |
[ study information coming soon!] |
||||||
[ go to web site ] |
[ study information coming soon!] |
||||||
|
[ study information coming soon!] |
[ study information coming soon!] |
||||||
|
[ study information coming soon!] |
[ study information coming soon!] |
||||||
|
[ study information coming soon!] |
[ go to web site ] |
||||||
[ go to web site ] |
|
||||||
|
|||||||
The Rare Diseases Clinical Research Network (RDCRN) is funded by the National Institute of Health (NIH) and the Office for Rare Diseases Research (ORDR). RDCRN was created to facilitate collaboration among experts in many different types of rare diseases. Our goal is to contribute to the research and treatment of rare diseases by working together to identify biomarkers for disease risk, disease severity and activity, and clinical outcome, while also encouraging development of new approaches to diagnosis, prevention, and treatment. More About the RDCRN > |